An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society …
TASC Steering Committee*, MR Jaff… - Journal of …, 2015 - journals.sagepub.com
The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC)
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …
Critical limb ischemia: an expert statement
MH Shishehbor, CJ White, BH Gray, MT Menard… - Journal of the American …, 2016 - jacc.org
Critical limb ischemia (CLI), the most advanced form of peripheral artery disease, is
associated with significant morbidity, mortality, and health care resource utilization. It is also …
associated with significant morbidity, mortality, and health care resource utilization. It is also …
[HTML][HTML] Global vascular guidelines on the management of chronic limb-threatening ischemia
Guideline Summary Chronic limb-threatening ischemia (CLTI) is associated with mortality,
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …
[HTML][HTML] ESVM Guideline on peripheral arterial disease
U Frank, S Nikol, J Belch, V Boc, M Brodmann… - Vasa, 2019 - econtent.hogrefe.com
The European Society of Vascular Medicine (ESVM) was founded in Paris in 2012 as a
confederation of already existing and emerging European societies of vascular medicine. At …
confederation of already existing and emerging European societies of vascular medicine. At …
[PDF][PDF] SCAI appropriate use criteria for peripheral arterial interventions: an update
In 2014, the Society for Cardiovascular Angiography and Interventions (SCAI) published the
first Appropriate Use Criteria (AUC) for endovascular therapy (EVT) for atherosclerotic …
first Appropriate Use Criteria (AUC) for endovascular therapy (EVT) for atherosclerotic …
Comparative effectiveness of plain balloon angioplasty, bare metal stents, drug-coated balloons, and drug-eluting stents for the treatment of infrapopliteal artery …
Purpose: To report a Bayesian network meta-analysis of randomized controlled trials (RCTs)
comparing bare metal stents (BMS), paclitaxel-coated balloons (PCBs), and drug-eluting …
comparing bare metal stents (BMS), paclitaxel-coated balloons (PCBs), and drug-eluting …
Drug-eluting stents and balloons—materials, structure designs, and coating techniques: a review
I Rykowska, I Nowak, R Nowak - Molecules, 2020 - mdpi.com
Controlled drug delivery is a matter of interest to numerous scientists from various domains,
as well as an essential issue for society as a whole. In the treatment of many diseases, it is …
as well as an essential issue for society as a whole. In the treatment of many diseases, it is …
Long‐term follow‐up of the PADI trial: percutaneous transluminal angioplasty versus drug‐eluting stents for infrapopliteal lesions in critical limb ischemia
MI Spreen, JM Martens, B Knippenberg… - Journal of the …, 2017 - Am Heart Assoc
Background Clinical outcomes reported after treatment of infrapopliteal lesions with drug‐
eluting stents (DESs) have been more favorable compared with percutaneous transluminal …
eluting stents (DESs) have been more favorable compared with percutaneous transluminal …
[HTML][HTML] Current developments in endovascular therapy of peripheral vascular disease
DG Kokkinidis, EJ Armstrong - Journal of thoracic disease, 2020 - ncbi.nlm.nih.gov
More than 200 million people worldwide have peripheral artery disease (PAD) or its most
severe manifestation, critical limb ischemia (CLI). While endovascular treatment has become …
severe manifestation, critical limb ischemia (CLI). While endovascular treatment has become …
Emerging and Future Therapeutic Options for Femoropopliteal and Infrapopliteal Endovascular Intervention.
DG Kokkinidis, EJ Armstrong - Interventional Cardiology Clinics, 2017 - europepmc.org
Despite recent advances in endovascular therapy for peripheral artery disease, current
technologies remain limited by rates of long-term restenosis and application to complex …
technologies remain limited by rates of long-term restenosis and application to complex …